Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients

NCT02052999 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythematotelangiectatic Rosacea
Papulopustular Rosacea

Interventions

DRUG: PAC-14028 cream 1%
OTHER: Vehicle
DRUG: Rozex gel 0.75%

Sponsor

Amorepacific Corporation